Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
The U.S. Food and Drug Administration (FDA) announced in a new drug safety communication is this week that it is ...
Over the past couple years covering the news about gadolinium-based contrast agent (GBCA) retention in the brain, skin ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
December 12, 2017 — Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance ...
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring ...
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MRI ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
October 10, 2017 — Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de ...
Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast ...
September 12, 2017 — The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
September 7, 2017 — The U.S. Food and Drug Administration (FDA) held a meeting of the Medical Imaging Drugs Advisory ...
September 6, 2017 — Guerbet LLC USA announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem ...
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
August 15, 2017 — The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the ...
Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...
July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix ...
July 17, 2017 — The American College of Radiology (ACR) recently revised its authoritative guide for the safe and ...
June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s imaging ...
May 25, 2017 — A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast ...
December 19, 2017 